PATENT CLAIM ANALYSIS

Application Number: 16158494
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["705", "002000"]

Abstract:
The present invention relates to a substance with pharmaceutical activity against a medical condition for use in a treatment of said medical condition in combination with a computer program product comprising instructions causing a computer to perform a method comprising the steps—providing a patient with a set of questions according to a question schedule, wherein said set of questions is specific to the pharmaceutical product;—collecting answers to said questions from said patient;—subjecting said answers to a set of functions specific for the set of questions and the pharmaceutical product thereby generating patient specific feedback information;—providing said feedback information to the patient; and optionally extracting clinically relevant information from said answers and providing said clinically relevant information to a database adapted for collecting clinically relevant information during clinical use of said substance. The invention further relates to a corresponding kit-of-parts comprising the substance and the computer program product, and the computer program product and its method as such.

Claim (Index 1):
Method for treatment or prevention of Acute Coronary Syndrome comprising the use of ticagrelor in combination with a computer having installed thereon a computer program product comprising instructions causing a computer to perform a method comprising the steps\n providing a patient undergoing an administration and dosing regimen with ticagrelor with a set of questions according to a question schedule, wherein said set of questions is specific to ticagrelor; collecting answers to said questions from said patient; subjecting said answers to a set of functions specific for the set of questions and ticagrelor thereby generating patient-specific feedback information; providing said feedback information to the patient with regard to said administration and/or dosing regimen, wherein said patient integrates said feedback information into said administration and/or dosing regimen; and repeating the above steps until the patient's blood levels of LDL are lowered.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 97.0
- Lexical Diversity: 2.43478
- Patent Class: 705.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13185990', '14162743', '12985356', '11377773', '12879267']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.0870682757972105
- 35 USC 102 Novelty (BERT): 0.4969761971139078
- Combined Prediction Score: 0.1280590679288802
- Mean Citation Score: 171.960578
- Max Citation Score: 178.87604
- Similarity Product: 112.80839564173698

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test